RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $38,461,000 | -11.8% | 1,781,437 | -10.1% | 60.35% | +22.3% |
| Q2 2019 | $43,592,000 | -19.7% | 1,981,437 | 0.0% | 49.33% | -8.3% |
| Q1 2019 | $54,311,000 | -32.2% | 1,981,437 | -33.5% | 53.78% | -32.7% |
| Q4 2018 | $80,141,000 | -7.9% | 2,981,437 | 0.0% | 79.96% | +10.6% |
| Q3 2018 | $86,969,000 | -30.1% | 2,981,437 | -25.1% | 72.32% | -7.7% |
| Q2 2018 | $124,460,000 | +57.1% | 3,981,437 | 0.0% | 78.39% | +39.6% |
| Q1 2018 | $79,231,000 | -31.5% | 3,981,437 | 0.0% | 56.15% | +7.4% |
| Q4 2017 | $115,701,000 | – | 3,981,437 | – | 52.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 810,000 | $19,845,000 | 8.20% |
| NEA Management Company, LLC | 4,912,306 | $108,316,000 | 5.41% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $46,403,000 | 3.57% |
| RA Capital Management | 5,471,067 | $134,041,000 | 2.86% |
| Samsara BioCapital, LLC | 345,293 | $8,460,000 | 1.97% |
| Altium Capital Management LP | 170,000 | $4,165,000 | 1.53% |
| Parkman Healthcare Partners LLC | 187,989 | $4,606,000 | 1.31% |
| Rock Springs Capital Management LP | 1,760,865 | $43,141,000 | 1.11% |
| EAM Investors, LLC | 198,699 | $4,868,000 | 1.06% |
| Prosight Management, LP | 80,000 | $1,960,000 | 1.05% |